19. Completion of Two-Dose Recombinant Zoster Vaccine Series in Adults 50 Years and Older

BACKGROUND: In 2017, the Advisory Committee on Immunization Practices preferentially recommended adjuvanted recombinant zoster vaccine (RZV) for adults ≥ 50 years as a two-dose series 2–6 months apart.(1) We evaluated two-dose RZV completion and factors associated with completion. METHODS: The study...

Descripción completa

Detalles Bibliográficos
Autores principales: Tseng, Hung-Fu, Qian, Lei, Wu, Jun, Luo, Yi, Sy, Lina S, Bruxvoort, Katia, Ackerson, Bradley
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Poster Abstracts
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776052/
http://dx.doi.org/10.1093/ofid/ofaa439.064

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7776052/
http://dx.doi.org/10.1093/ofid/ofaa439.064

Ejemplares similares